Deformation of transcatheter heart valves with mitral valve-in-valve.


Journal

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
ISSN: 1969-6213
Titre abrégé: EuroIntervention
Pays: France
ID NLM: 101251040

Informations de publication

Date de publication:
30 Oct 2023
Historique:
medline: 30 10 2023
pubmed: 30 10 2023
entrez: 30 10 2023
Statut: aheadofprint

Résumé

The use of oversizing in mitral valve-in-valve (MViV) procedures can lead to non-uniform expansion of transcatheter heart valves (THV). This may have implications for THV durability. The objective of this study was to assess the extent and predictors of THV deformation in MViV procedures. We examined 33 patients who underwent MViV with SAPIEN prostheses. The extent of THV deformation (deformation index, eccentricity, neosinus volume, asymmetric leaflet expansion and vertical deformation) and hypoattenuating leaflet thickening (HALT) were assessed using cardiac computed tomography (CT), performed prospectively at 30 days post-procedure. For descriptive purposes, the THV deformation index was calculated, with values >1.00 representing a more hourglass shape. Non-uniform underexpansion of THV was common after MViV implantation, with a median expansion area of 74.0% (interquartile range 68.1-84.1) at the narrowest level and a THV deformation index of 1.21 (1.13-1.29), but circularity was maintained with eccentricity ranging from 0.24 to 0.28.The degree of oversizing was a key factor associated with greater underexpansion and a higher deformation index (β=-0.634; p<0.001; β=0.594; p<0.001, respectively). Overall, the incidence of HALT on the 30-day postprocedural CT was 27.3% (9 of 33). Most patients (32 of 33) were on anticoagulation therapy, but the prothrombin time and international normalised ratio (PT-INR) at the time of the CT scan was <2.5 in 23 of 32 patients. Among patients with a PT-INR of <2.5, HALT was predominantly observed with a high THV deformation index of ≥1.18. THV deformation, i.e., underexpansion and an hourglass shape, commonly occurs after MViV implantation and is negatively affected by excessive oversizing. Optimising THV expansion during MViV could potentially prevent HALT.

Sections du résumé

BACKGROUND BACKGROUND
The use of oversizing in mitral valve-in-valve (MViV) procedures can lead to non-uniform expansion of transcatheter heart valves (THV). This may have implications for THV durability.
AIMS OBJECTIVE
The objective of this study was to assess the extent and predictors of THV deformation in MViV procedures.
METHODS METHODS
We examined 33 patients who underwent MViV with SAPIEN prostheses. The extent of THV deformation (deformation index, eccentricity, neosinus volume, asymmetric leaflet expansion and vertical deformation) and hypoattenuating leaflet thickening (HALT) were assessed using cardiac computed tomography (CT), performed prospectively at 30 days post-procedure. For descriptive purposes, the THV deformation index was calculated, with values >1.00 representing a more hourglass shape.
RESULTS RESULTS
Non-uniform underexpansion of THV was common after MViV implantation, with a median expansion area of 74.0% (interquartile range 68.1-84.1) at the narrowest level and a THV deformation index of 1.21 (1.13-1.29), but circularity was maintained with eccentricity ranging from 0.24 to 0.28.The degree of oversizing was a key factor associated with greater underexpansion and a higher deformation index (β=-0.634; p<0.001; β=0.594; p<0.001, respectively). Overall, the incidence of HALT on the 30-day postprocedural CT was 27.3% (9 of 33). Most patients (32 of 33) were on anticoagulation therapy, but the prothrombin time and international normalised ratio (PT-INR) at the time of the CT scan was <2.5 in 23 of 32 patients. Among patients with a PT-INR of <2.5, HALT was predominantly observed with a high THV deformation index of ≥1.18.
CONCLUSIONS CONCLUSIONS
THV deformation, i.e., underexpansion and an hourglass shape, commonly occurs after MViV implantation and is negatively affected by excessive oversizing. Optimising THV expansion during MViV could potentially prevent HALT.

Identifiants

pubmed: 37899719
pii: EIJ-D-23-00614
doi: 10.4244/EIJ-D-23-00614
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Miho Fukui (M)

Cardiovascular Imaging Research Center and Core Lab, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.

Atsushi Okada (A)

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.

Marcus R Burns (MR)

Allina Health Minneapolis Heart Institute - Minneapolis, Abbott Northwestern Hospital, Minneapolis, MN, USA.

Hirotomo Sato (H)

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.

Kiahltone R Thao (KR)

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.

Cheng Wang (C)

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.

Hideki Koike (H)

Cardiovascular Imaging Research Center and Core Lab, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.

Nadira Hamid (N)

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.
Allina Health Minneapolis Heart Institute - Minneapolis, Abbott Northwestern Hospital, Minneapolis, MN, USA.

Maurice Enriquez-Sarano (M)

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.

John R Lesser (JR)

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.
Allina Health Minneapolis Heart Institute - Minneapolis, Abbott Northwestern Hospital, Minneapolis, MN, USA.

Joao L Cavalcante (JL)

Cardiovascular Imaging Research Center and Core Lab, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.
Allina Health Minneapolis Heart Institute - Minneapolis, Abbott Northwestern Hospital, Minneapolis, MN, USA.

Paul Sorajja (P)

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.
Allina Health Minneapolis Heart Institute - Minneapolis, Abbott Northwestern Hospital, Minneapolis, MN, USA.

Vinayak N Bapat (VN)

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.
Allina Health Minneapolis Heart Institute - Minneapolis, Abbott Northwestern Hospital, Minneapolis, MN, USA.

Classifications MeSH